【24h】

Amplification options in unilateral aural atresia: An active middle ear implant or a bone conduction device?

机译:单侧听觉闭锁的放大选择:活动中耳植入物或骨传导装置?

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: There is no consensus on treatment of patients with congenital unilateral aural atresia. Currently, 3 intervention options are available, namely, surgical reconstruction, application of a bone-conduction device (BCD), or application of a middle ear implant. OBJECTIVE: The present study aims to compare the BCD with the application of a middle ear implant. We hypothesized that cross-hearing (stimulating the cochlea by means of bone conduction contralateral to the implanted side) would cause BCD users to have difficulty performing localization tasks. METHODS: Audiologic data of 4 adult patients with a middle ear implant coupled directly to the cochlea were compared with data of 4 adult patients fitted with an osseointegrated BCD. All patients were fitted during adulthood. The emphasis of this study is on directional hearing. RESULTS: The middle ear implant and the BCD improved sound localization of patients with congenital unilateral aural atresia. Unaided scores demonstrate a large variation. CONCLUSION: Our results demonstrate that there was no advantage of the middle ear implant over the BCD for directional hearing in patients who had no amplification in childhood. The BCD users had the best bandwidth.
机译:背景:先天性单侧听觉闭锁的治疗尚无共识。当前,有3种干预选择可用,即手术重建,骨传导装置(BCD)的应用或中耳植入物的应用。目的:本研究旨在比较BCD与中耳植入物的应用。我们假设交叉听力(通过与植入侧对侧的骨传导刺激耳蜗)将使BCD用户难以执行定位任务。方法:将4例成年患者中耳植入物直接耦合到耳蜗的听力数据与4例骨结合BCD成年人的数据进行了比较。所有患者在成年期都适合。这项研究的重点是定向听觉。结果:中耳植入物和BCD改善了先天性单侧听觉闭锁患者的声音定位。无助得分显示出很大的差异。结论:我们的结果表明,对于儿童期无扩增的患者,中耳植入物比BCD定向听觉没有优势。 BCD用户拥有最佳带宽。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号